Suppressor cells in demyelinating disease: a new paradigm for the new millennium (Q33850705)

29 July 2017

1 reference

title

Suppressor cells in demyelinating disease: a new paradigm for the new millennium (English)

1 reference

29 July 2017

main subject

demyelinating disease

1 reference

Lenz DC

1

1 reference

29 July 2017

Swanborg RH

series ordinal

2

1 reference

29 July 2017

publication date

1 December 1999

1 reference

Journal of Neuroimmunology

29 July 2017

published in

1 reference

29 July 2017

volume

100

1 reference

29 July 2017

issue

1-2

1 reference

29 July 2017

page(s)

53-57

1 reference

Die and let live: eliminating dangerous lymphocytes

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Evidence for suppressor cells in Lewis rats' experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Suppressive activity of long-term myelin basic protein-specific SJL T cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Prevention of experimental allergic encephalomyelitis in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Induction of TH1 and TH2 immunity in neonatal mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Immunoregulatory T-cell pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Soluble antigen therapy induces apoptosis of autoreactive T cells preferentially in the target organ rather than in the peripheral lymphoid organs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

1 reference

7 January 2021

Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Transforming growth factor-beta 1 inhibits tumor necrosis factor-alpha/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Acquired resistance to experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900208-8

7 January 2021

10.1016/S0165-5728(99)00208-8

Identifiers

DOI

1 reference

29 July 2017

1 reference